Jane Hsiao

Chief technical officer and vice chairman of Opko Health, which she cofounded in 2007 with biotech billionaire Phillip Frost. Opko has developed and acquired such products as Varubi, for chemotherapy induced nausea; 4Kscore, a prostate cancer test; and Rayaldee, a treatment for vitamin D deficiencies in patients with kidney disease. Shares of the firm peaked last June just after it submitted Rayaldee for FDA approval (it was rejected in March) and before it announced it would acquire the nation's third largest clinical diagnostic laboratory, Bio-Reference Laboratories. The company, which has yet to make a profit, is trading well below its highs.Frost's close confidante and business partner, she has been working with him for years at various pharma outfits like Ivax and Non-Invasive Monitoring Systems. Native of Taiwan. Educated there and also at the U. of Illinois; she has a Ph.D. and an M.B.A. Bachelor of Arts / Science, National Taiwan University; Ph.D, University of Illinois, Chicago